Capio AB (Publ) Interim Report January - March 2017

Digital test consultations within primary care will start during the spring and summer with a full roll-out of digital doctor consultations from the autumn and onwards.

In France the aim this year is to keep the EBITA margin flat and in a longer perspective increase margins despite the tough pricing environment. The tools for this are a continued implementation of Modern Medicine leading to a more Rapid Recovery for patients and a larger proportion of treatments being made without over-night stay in hospital. Improved medical quality and expansions in new specialties will continue to drive the patient growth.

Germany continues the good trend from last year. 4.6% organic sales growth and 22% EBITA growth do not only reflect an Easter calendar effect, but also continuous improvements in the general hospitals.

The focus going forward is of course on securing the ongoing positive trends in the current business by intensified work with Modern Medicine and Modern Management.

Since the end of 2016, we have increased acquisition activities. We have so far added net sales of MSEK 900 from acquisitions on a full year basis. Acquisitions made have margins above group average and will contribute positively to the margin develop­ment in 2017 and will gradually be enhanced further by synergies. The acquisition activity is expected to continue.

Thomas Berglund
President and CEO

Presentation of the interim report

Investors, analysts and media are invited to participate in a telephone conference on May 3, 2017 at 13.30 pm (CET). President and CEO Thomas Berglund and CFO Olof Bengtsson will present the report and answer questions. The telephone conference will be audio casted live on www.capio.com. To participate in the telephone conference, please register at www.capio.com and dial in five minutes prior to the start of the conference call.

Sweden: +46-8-566-426-92

UK: +44-203-008-98-01

US: +1-855-753-22-35

Finland: +35-898-171-04-93

France: +33-170-75-07-12

Prior to the start of the telephone conference, presentation slides will be available at www.capio.com.

A recorded version of the audio cast will be available at www.capio.com during the afternoon (CET).

For further information

Thomas Berglund
President and CEO
Telephone: +46-733-88-86-00
E-mail: thomas.berglund@capio.com

Olof Bengtsson
CFO
Telephone: +46-761-18-74-69
E-mail: olof.bengtsson@capio.com

Kristina Ekeblad
Investor Relations Manager
Telephone: +46-708-31-19-40
E-mail: kristina.ekeblad@capio.com

Henrik Brehmer
SVP Group Communication and Public Affairs
Telephone: +46-761-11-34-14
E-mail: henrik.brehmer@capio.com

For further information regarding Capio's IR activities, refer to www.capio.com

This information is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person Henrik Brehmer set out above, at 12.30 (CET) on May 3, 2017.

About Capio

Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Since the Danish operation was acquired at the beginning of 2017, Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2016, Capio's 12,435 employees provided healthcare services during 4.7 million patient visits across the Group's facilities, generating net sales of MSEK 14,069. Capio operates across three geographic segments: Nordic (54% of Group net sales 2016), France (38% of Group net sales 2016) and Germany (8% of Group net sales 2016). For more information about Capio, please see www.capio.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/capio-ab/r/capio-ab--publ--interim-report-january---march-2017,c2256436

The following files are available for download: